BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe
- User Conference Previews eClinical Advancements
NEWTOWN, Pennsylvania, March 4, 2015 /PRNewswire/ -- BioClinica®, Inc., a leading specialty clinical trials services and technology provider, today announced that clinical trial professionals representing 20 organizations and 10 countries convened at its annual European User Conference in Barcelona, Spain to discuss the use of its eClinical technologies to overcome clinical development challenges. BioClinica's eClinical technologies include: the Microsoft Office-Smart OnPoint CTMS; Express EDC; Trident IRT; predictive clinical supply Optimizer; and Compass, the risk-based intelligent monitoring solution.
Logo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
Representatives from top pharma, medical device and biotech companies as well as CROs led presentations and case studies including Nestlé, ClinTec International, Isis Pharmaceuticals, inVentiv Health, Biosense Webster, Janssen, Amarantus BioScience, Cerbomed, and others. Martijn Princen, BioClinica's Head of European eClinical Sales, remarked, "The event gives us another window into the pressing needs of our customers and helps our product development team respond with fresh approaches. It is also an effective forum where they can exchange valuable experiences and successes using BioClinica products."
BioClinica Vice President of Product Development, Chip deVillafranca, discussed recent strides made to keep customers' clinical trials on the leading edge with enhancements including integration, analytics, workflow, usability, mobility, and self-service functionality. Product innovations were showcased in hands-on demonstrations. The keynote, "Putting Risk-Based Monitoring (RBM) into Practice," was delivered by Boehringer Ingelheim's Global Project Team Leader for RBM implementation Mireille Zerola, a member of the TransCelerate Biopharma RBM work stream. She shared about her company's journey in implementing its own RBM solution, serving as an incubator of innovation for others.
Zerola later teamed with BioClinica's Vice President of Clinical Innovation, Courtney McBean on an interactive session about obstacles to RBM implementation. The two RBM experts showed how Compass can ease the transition to centralized and off-site monitoring taking a risk-based, quality management approach. They will further explore this topic in an upcoming live webinar to be hosted by BioClinica on March 5th, Overcoming Barriers to Risk Based Monitoring.
Upcoming events featuring BioClinica's experts and eClinical technologies include:
- Clinical Innovations Congress, London, United Kingdom, March 10-11
- Association for Clinical Data Management Annual Conference, Brussels, Belgium, March 18
- BioClinica Global User Conference, Orlando Florida, USA, May 5-6
- Outsourcing in Clinical Trials Europe, Dusseldorf, Germany, May 19-20
About BioClinica, Inc.
BioClinica accelerates the development of new medical therapies by delivering expertise and technologies that enhance clinical research, worldwide. Our industry-leading medical imaging services, cardiac safety, and enterprise eClinical platform bring a new level of quality and efficiency to every phase of clinical development. Our experience spans three decades and includes thousands of studies in all therapeutic areas, from design and management, through submission and post-approval. BioClinica serves more than 400 pharmaceutical, biotechnology, and device companies – including all the top 20 - through a network of offices in the U.S., Europe, and Asia.
Share this article